Characterization of Binding Properties of Monoglyceride Lipase Inhibitors by a Versatile Fluorescence‐Based Technique
10.1016/j.ab.2009.12.009 · doi-reference
Pharmacologic Characterization of JNJ‐42226314, [1‐(4‐Fluorophenyl)indol‐5‐Yl]‐[3‐[4‐(Thiazole‐2‐Carbonyl)Piperazin‐1‐Yl]azetidin‐1‐Yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor
10.1124/jpet.119.262139 · doi-reference
Chiral 1,3,4‐Oxadiazol‐2‐Ones as Highly Selective FAAH Inhibitors
10.1021/jm400923s · doi-reference
Revisiting 1,3,4‐Oxadiazol‐2‐Ones: Utilization in the Development of ABHD6 Inhibitors
10.1016/j.bmc.2015.08.030 · doi-reference
Optimization of 1,2,5‐Thiadiazole Carbamates as Potent and Selective ABHD6 Inhibitors
10.1002/cmdc.201402453 · doi-reference
Biochemical and Pharmacological Characterization of Human α/β‐Hydrolase Domain Containing 6 (ABHD6) and 12 (ABHD12)
10.1194/jlr.m030411 · doi-reference
Development of a Novel 18F‐Labeled Reversible‐Binding Radioligand for Imaging Monoacylglycerol Lipase With Positron Emission Tomography
10.1016/j.apsb.2025.05.041 · doi-reference
Development of High Brain‐Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging
10.1021/acs.jmedchem.1c01706 · doi-reference
A Novel Monoacylglycerol Lipase‐Targeted 18F‐Labeled Probe for Positron Emission Tomography Imaging of Brown Adipose Tissue in the Energy Network
10.1038/s41401-022-00912-8 · doi-reference
Novel Reversible‐Binding PET Ligands for Imaging Monoacylglycerol Lipase Based on the Piperazinyl Azetidine Scaffold
10.1021/acs.jmedchem.1c00747 · doi-reference
Design, Synthesis, and Evaluation of (4R)‐1‐{3‐[2‐(18F)Fluoro‐4‐Methylpyridin‐3‐Yl]phenyl}‐4‐[4‐(1,3‐Thiazol‐2‐Ylcarbonyl)piperazin‐1‐Yl]pyrrolidin‐2‐One ([18F]T‐401) as a Novel Positron‐Emission Tomography Imaging Agent for Monoacylglycerol Lipase
10.1021/acs.jmedchem.8b01576 · doi-reference
Multi‐Parameter Optimization: Development of a Morpholin‐3‐One Derivative With an Improved Kinetic Profile for Imaging Monoacylglycerol Lipase in the Brain
10.1016/j.ejmech.2022.114750 · doi-reference
Discovery, Synthesis and Evaluation of Novel Reversible Monoacylglycerol Lipase Radioligands Bearing a Morpholine‐3‐One Scaffold
10.1016/j.nucmedbio.2022.02.002 · doi-reference
Design, Synthesis, and Evaluation of 18F‐Labeled Monoacylglycerol Lipase Inhibitors as Novel Positron Emission Tomography Probes
10.1021/acs.jmedchem.9b00936 · doi-reference
Development of a Highly‐Specific 18F‐Labeled Irreversible Positron Emission Tomography Tracer for Monoacylglycerol Lipase Mapping
10.1016/j.apsb.2021.01.021 · doi-reference
Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a “Tail Switching” Strategy on a Piperazinyl Azetidine Skeleton
10.1021/acs.jmedchem.8b01778 · doi-reference
Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand With High Specificity
10.1021/acs.jmedchem.9b00847 · doi-reference
Synthesis and Preclinical Evaluation of [11C]MA‐PB‐1 for In Vivo Imaging of Brain Monoacylglycerol Lipase (MAGL)
10.1016/j.ejmech.2017.04.066 · doi-reference
In Vitro and In Vivo Evaluation of 11C‐Labeled Azetidinecarboxylates for Imaging Monoacylglycerol Lipase by PET Imaging Studies
10.1021/acs.jmedchem.7b01400 · doi-reference
Synthesis and Preclinical Evaluation of Sulfonamidobased [11C‐Carbonyl]‐Carbamates and Ureas for Imaging Monoacylglycerol Lipase
10.7150/thno.15257 · doi-reference
Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development
10.1021/acs.jmedchem.0c01459 · doi-reference
Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography
10.1002/anie.200800222 · doi-reference
Molecular Imaging in Drug Development
10.1038/nrd2290 · doi-reference
Molecular Imaging With PET
10.1021/cr0782426 · doi-reference
